New androgen receptor genomic targets show an interaction with the ETS1 transcription factor
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
The androgen receptor (AR) initiates important developmental and oncogenic transcriptional pathways. The AR is known to bind as a homodimer to 15-base pair bipartite palindromic androgen-response elements; however, few direct AR gene targets are known. To identify AR promoter targets, we used chromatin immunoprecipitation with on-chip detection of genomic fragments. We identified 1,532 potential AR-binding sites, including previously known AR gene targets. Many of the new AR target genes show altered expression in prostate cancer. Analysis of sequences underlying AR-binding sites showed that more than 50% of AR-binding sites did not contain the established 15 bp AR-binding element. Unbiased sequence analysis showed 6-bp motifs, which were significantly enriched and were bound directly by the AR in vitro. Binding sequences for the avian erythroblastosis virus E26 homologue (ETS) transcription factor family were also highly enriched, and we uncovered an interaction between the AR and ETS1 at a subset of AR promoter targets.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Such a situation has also been observed for similar studies on the androgen receptor and may suggest compensation or redundancy in transcriptional control (Massie et al., 2007).”
From Dissecting the Unique Role of the Retinoblastoma Tumor Suppressor during Cellular Senescence (2010) · cites this paper as Massie et al., 2007
In the citing paper
“The involvement of the AR in normal prostate development, coupled with the prevalence of ETS-binding sequences at AR-bound regions (177), implies a cooperative interaction that could play a role in ETS-mediated prostate oncogenesis (Figure 7).”
From Genomic and biochemical insights into the specificity of ETS transcription factors (2011) · cites this paper as [177]
In the citing paper
“AR has evolved in a manner that allows it to tolerate levels of sequence degeneracy for proper development, with this enhanced flexibility conferred through a plastic dimer interface and an extended hinge, both serving as regulatory mechanisms that allow AR to bind primarily half sites and other degenerate sequences in vivo”
From Allosteric interactions prime androgen receptor dimerization and activation (2022) · cites this paper as Massie et al., 2007
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer
Tomlins, S. A., Rhodes, D. R., Perner, S., Dhanasekaran, S. M., Mehra, R., Sun, X.-W., Varambally, S., Cao, X., Tchinda, J., Kuefer, R., et al. (2005) · Science · doi:10.1126/science.1117679 · Cited by 3,846
Molecular determinants of resistance to antiandrogen therapy
Chen, C. D., Welsbie, D. S., Tran, C., Baek, S. H., Chen, R., Vessella, R., Rosenfeld, M. G., & Sawyers, C. L. (2004) · Nature Medicine · doi:10.1038/nm972 · Cited by 2,278 · cited 3×
“EMBO open New androgen receptor genomic targets show an interaction with the ETS1 transcription factor”
BackgroundMatInspector and beyond: promoter analysis based on transcription factor binding sites
Cartharius, K., Frech, K., Grote, K., Klocke, B., Haltmeier, M., Klingenhoff, A., Frisch, M., Bayerlein, M., & Werner, T. (2005) · Bioinformatics · doi:10.1093/bioinformatics/bti473 · Cited by 1,979
Carroll, J. S., Liu, X. S., Brodsky, A. S., Li, W., Meyer, C. A., Szary, A. J., Eeckhoute, J., Shao, W., Hestermann, E. V., Geistlinger, T. R., et al. (2005) · Cell · doi:10.1016/j.cell.2005.05.008 · Cited by 1,384
Cancer incidence and mortality in Europe, 2004
Boyle, P., & Ferlay, J. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi098 · Cited by 1,217
Cancer incidence and mortality in Europe
Levi, F., Maisonneuve, P., Filiberti, R., La Vecchia, C., & Boyle, P. (1989) · Sozial- und Präventivmedizin · doi:10.1007/bf02148558 · Cited by 968
Integrative molecular concept modeling of prostate cancer progression
Tomlins, S. A., Mehra, R., Rhodes, D. R., Cao, X., Wang, L., Dhanasekaran, S. M., Kalyana-Sundaram, S., Wei, J. T., Rubin, M. A., Pienta, K. J., et al. (2007) · Nature Genetics · doi:10.1038/ng1935 · Cited by 922
Varambally, S., Yu, J., Laxman, B., Rhodes, D. R., Mehra, R., Tomlins, S. A., Shah, R. B., Chandran, U., Monzon, F. A., Becich, M. J., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.10.001 · Cited by 800
Holzbeierlein, J., Lal, P., LaTulippe, E., Smith, A., Satagopan, J., Zhang, L., Ryan, C., Smith, S., Scher, H., Scardino, P., et al. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63112-4 · Cited by 577 · cited 1×
“Gene Ontology analysis Oncogenomics Haag et al (2005) Velsaco et al (2004) Holzbeierlein et al (2004) Varambally et al (2005) A”
Hata, A., Seoane, J., Lagna, G., Montalvo, E., Hemmati-Brivanlou, A., & Massagué, J. (2000) · Cell · doi:10.1016/s0092-8674(00)81561-5 · Cited by 420
Cited by
Items 101–200 of 259
Inflammation as the primary aetiological agent of human prostate cancer: A stem cell connection?
Maitland, N. J., & Collins, A. T. (2008) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21843 · Cited by 50
“…[Roche et al., 1992] which can be arranged in both direct and inverted repeat orientations [Verrijdt et al., 2003], a recognition specificity which has recently been extended to include the necessity for binding in some genes to an ets1 transcription factor binding site [Massie et al., 2007].”
BackgroundAndrogen Physiology: Receptor and Metabolic Disorders
McEwan, I. J., & Brinkmann, A. O. (2016) · Cited by 46
The Stress Response Mediator ATF3 Represses Androgen Signaling by Binding the Androgen Receptor
Wang, H., Jiang, M., Cui, H., Chen, M., Buttyan, R., Hayward, S. W., Hai, T., Wang, Z., & Yan, C. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.00159-12 · Cited by 47
“However, given that a large portion of ARbinding sites revealed by genome-wide ChIP-microarray (ChIPchip) or ChIP with high-throughput sequencing (ChIP-seq) approaches do not seem to contain ARE (40, 61), it would be interesting to explore whether AR could be recruited to these genomic sites through binding to ATF3.”
BackgroundGrillo, G., Keshavarzian, T., Linder, S., Arlidge, C., Mout, L., Nand, A., Teng, M., Qamra, A., Zhou, S., Kron, K. J., et al. (2023) · Cancer Discovery · doi:10.1158/2159-8290.cd-23-0331 · Cited by 42
“AR also has strong binding capacities for the AR “half-site” (58); therefore, we investigated the enrichment of both ARE and AR half-sites within TE families enriched for the AR cistrome.”
Hormonal regulation of β2‐adrenergic receptor level in prostate cancer
Ramberg, H., Eide, T., Krobert, K. A., Levy, F. O., Dizeyi, N., Bjartell, A. S., Abrahamsson, P., & Taskén, K. A. (2008) · The Prostate · doi:10.1002/pros.20778 · Cited by 42
Rajan, P., Dalgliesh, C., Carling, P. J., Buist, T. J., Zhang, C., Grellscheid, S. N., Armstrong, K., Stockley, J., Simillion, C., Gaughan, L., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0029088 · Cited by 43
“DNA sequences termed androgen response elements (AREs) [3,4].”
BackgroundResultInfluentialETS‐targeted therapy: can it substitute for MEK inhibitors?
Tetsu, O., & McCormick, F. P. (2017) · Clinical and Translational Medicine · doi:10.1186/s40169-017-0147-4 · Cited by 45
“A recent report demonstrated that ETS1-binding sequences were specifically enriched in AR-targeted genes [107].”
BackgroundCurrie, S. L., Doane, J. J., Evans, K. S., Bhachech, N., Madison, B. J., Lau, D., McIntosh, L. P., Skalicky, J. J., Clark, K. A., & Graves, B. J. (2017) · Journal of Molecular Biology · doi:10.1016/j.jmb.2017.06.024 · Cited by 48
Interplay between steroid signalling and microRNAs: implications for hormone-dependent cancers
Fletcher, C. E., Dart, D. A., & Bevan, C. L. (2014) · Endocrine Related Cancer · doi:10.1530/erc-14-0208 · Cited by 37
“Furthermore, KHSRP is itself a target of AR signalling hence could mediate androgen regulation of this miR subset (Massie et al. 2007; C E Fletcher, D A Dart and C L Bevan, unpublished observations).”
BackgroundSmith, A. M., Findlay, V. J., Bandurraga, S. G., Kistner‐Griffin, E., Spruill, L., Liu, A., Golshayan, A., & Turner, D. P. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs007 · Cited by 38
Independence of HIF1a and androgen signaling pathways in prostate cancer
Tran, M. G. B., Bibby, B. A. S., Yang, L., Lo, F., Warren, A. Y., Shukla, D., Osborne, M., Hadfield, J., Carroll, T., Stark, R., et al. (2020) · BMC Cancer · doi:10.1186/s12885-020-06890-6 · Cited by 40
Self-citationGür, S., Alzweri, L. M., Yilmaz‐Oral, D., Kaya‐Sezginer, E., Abdel‐Mageed, A. B., Dick, B. P., Sikka, S. C., Öztekin, Ç. V., & Hellstrom, W. J. G. (2020) · Andrology · doi:10.1111/andr.12866 · Cited by 40
Nuclear Receptor Location Analyses in Mammalian Genomes: From Gene Regulation to Regulatory Networks
Deblois, G., & Giguère, V. (2008) · Molecular Endocrinology · doi:10.1210/me.2007-0546 · Cited by 36
“Likewise, ETS1 regulates the transcriptional activity of AR (47).”
BackgroundMethodCurrie, S. L., Lau, D., Doane, J. J., Whitby, F. G., Okon, M., McIntosh, L. P., & Graves, B. J. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx068 · Cited by 40
“Besides USF1 (13), candidates include the AP1 factors (44) and the androgen receptor (22,62–64).”
Minges, J. T., Su, S., Grossman, G., Blackwelder, A. J., POP, E. A., Mohler, J. L., & Wilson, E. M. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.428409 · Cited by 37
“MAGE-A11 also may stabilize AR dimers bound to weaker ARE half-sites, which are common among androgen-regulated genes (46, 47).”
BackgroundRodgers, J. J., McClure, R. W., Epis, M. R., Cohen, R. J., Leedman, P. J., Harvey, J. M., BioResource, A. P. C., Thomas, M. A., & Bentel, J. M. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27446 · Cited by 39
Little, G. H., Baniwal, S. K., Adisetiyo, H., Groshen, S., Chimge, N.-O., Kim, S., Khalid, O., Hawes, D., Jones, J. O., Pinski, J., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2003 · Cited by 35
“Contributing to changes in its genomic locations and activities are AR co-activators and collaborating DNA-binding proteins such as FOXA1, NKX3-1, GATA2, RUNX2 and members of the ETS family of transcription factors (6-9).”
BackgroundThe ubiquitin-proteasome system in prostate cancer and its transition to castration resistance
Voutsadakis, I. A., & Papandreou, C. N. (2010) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2010.03.013 · Cited by 36
“[95] Massie CE, Adryan B, Barbosa-Morais NL, et al.”
BackgroundChemical castration and anti‐androgens induce differential gene expression in prostate cancer
Lehmusvaara, S., Erkkilä, T., Urbanucci, A., Waltering, K. K., Seppälä, J., Larjo, A., Tuominen, V. J., Isola, J. J., Kujala, P. M., Lähdesmäki, H. J., et al. (2012) · The Journal of Pathology · doi:10.1002/path.4027 · Cited by 38
Moehren, U., Denayer, S., Podvinec, M., Verrijdt, G., & Claessens, F. (2008) · Biochemical Journal · doi:10.1042/bj20071352 · Cited by 36
The androgen receptor malignancy shift in prostate cancer
Copeland, B. T., Pal, S. K., Bolton, E. C., & Jones, J. O. (2018) · The Prostate · doi:10.1002/pros.23497 · Cited by 36
An AR-Skp2 pathway for proliferation of androgen-dependent prostate-cancer cells
Wang, H., Sun, D., Ji, P., Mohler, J. L., & Zhu, L. (2008) · Journal of Cell Science · doi:10.1242/jcs.030742 · Cited by 33
“, 2001), and ChIP-on-chip screens (Massie et al., 2007; Wang et al., 2007) with cultured LNCaP cells stimulated with androgen.”
BackgroundPhosphodiesterase Type 5 Regulation in the Penile Corpora Cavernosa
Lin, C. (2009) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2008.01179.x · Cited by 31
Sampson, N., Ruiz, C. F., Zenzmaier, C., Bubendorf, L., & Berger, P. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.06.040 · Cited by 31
Aversa, A., Duca, Y., Condorelli, R. A., Calogero, A. E., & Vignera, S. L. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00225 · Cited by 35
“Finally, two studies that have looked for androgenresponsive genes in the whole human genome and they found respectively 524 and 1,532 potential AR-binding sites, but PDE5A gene was not among them (40, 41).”
BackgroundRanBP10 acts as a novel coactivator for the androgen receptor
Harada, N., Yokoyama, T., Yamaji, R., Nakano, Y., & Inui, H. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.01.072 · Cited by 30
“When LNCaP cells are stimulated with synthetic androgen R1881, AR binds to the promoter region of RanBP10 [18].”
Weber, H., Ruoff, R., & Garabedian, M. J. (2021) · PLoS Genetics · doi:10.1371/journal.pgen.1008540 · Cited by 32
Lack of direct androgen regulation of PDE5 expression
Yang, R., Huang, Y., Lin, G., Wang, G., Hung, S., Dai, Y., Sun, Z.-Y., Lue, T. F., & Lin, C. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.01.144 · Cited by 29
“These negative results regarding possible androgen regulation of PDE5 expression were further supported by 3 recent studies in which genome-wide searches for androgen receptor-bound genes were performed [29;30;31].”
ResultKerkhofs, S., Dubois, V., Gendt, K. D., Helsen, C., Clinckemalie, L., Spans, L., Schuit, F. C., Boonen, S., Vanderschueren, D., Saunders, P. T. K., et al. (2012) · The FASEB Journal · doi:10.1096/fj.11-202283 · Cited by 34
Li, W., & Zhao, Y. (2018) · Asian Journal of Andrology · doi:10.4103/aja.aja_32_18 · Cited by 32
The calcium sensor STIM1 is regulated by androgens in prostate stromal cells
Berry, P. A., Birnie, R., Droop, A., Maitland, N. J., & Collins, A. T. (2011) · The Prostate · doi:10.1002/pros.21384 · Cited by 28
“AREs are typically partial direct repeats of a TGTTCT motif with a three base spacer [15].”
BackgroundInfluentialMeller, S., Bicker, A., Montani, M., Ikenberg, K., Rostamzadeh, B., Sailer, V. W., Wild, P. J., Dietrich, D., Uhl, B., Sulser, T., et al. (2014) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-014-1646-y · Cited by 29
Role of Hormones in the Regulation of RACK1 Expression as a Signaling Checkpoint in Immunosenescence
Racchi, M., Buoso, E., Ronfani, M., Serafini, M. M., Galasso, M., Lanni, C., & Corsini, E. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18071453 · Cited by 31
“In fact, different spacer-lengths or different hexamer-orientations have been proposed [54,55].”
BackgroundAndrogen Receptor-CaMKK2 Axis in Prostate Cancer and Bone Microenvironment
Dadwal, U. C., Chang, E. S., & Sankar, U. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00335 · Cited by 28
“However, in contrast to previous studies (82, 87, 106, 107), these authors provide evidence for an inhibitory role for CaMKK2 to AR signaling and hypothesize that while CaMKK2 supports growth of tumors in early PCa, it inhibits excessive proliferation in CRPC (108).”
ResultErectile Dysfunction in Men on the Rise: Is There a Link with Endocrine Disrupting Chemicals?
Cripps, S. M., Mattiske, D. M., & Pask, A. J. (2021) · Sexual Development · doi:10.1159/000516600 · Cited by 28
“, 2013] and that genome-wide searches for genes regulated by androgens in human cells did not yield PDE5A as a candidate [Bolton et al., 2007; Massie et al., 2007].”
BackgroundNuclear Receptor Coregulators in Hormone-Dependent Cancers
Jafari, H., Hussain, S., & Campbell, M. J. (2022) · Cancers · doi:10.3390/cancers14102402 · Cited by 35
Thomas, M. A., Preece, D. M., & Bentel, J. M. (2009) · Biochemical Journal · doi:10.1042/bj20091109 · Cited by 34
Androgen Regulates Mafb Expression Through its 3′UTR During Mouse Urethral Masculinization
Matsushita, S., Suzuki, K., Ogino, Y., Hino, S., Sato, T., Suyama, M., Μatsumoto, T., Omori, A., Inoue, S., & Yamada, G. (2015) · Endocrinology · doi:10.1210/en.2015-1586 · Cited by 28
Buoso, E., Galasso, M., Serafini, M. M., Ronfani, M., Lanni, C., Corsini, E., & Racchi, M. (2017) · Cellular Signalling · doi:10.1016/j.cellsig.2017.02.010 · Cited by 34
New Opportunities for Targeting the Androgen Receptor in Prostate Cancer
Centenera, M. M., Selth, L. A., Ebrahimie, E., Butler, L. M., & Tilley, W. D. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a030478 · Cited by 30
“GATA2, and Oct1 that facilitate access of AR to the chromatin (Bolton et al. 2007; Massie et al. 2007; Wang et al. 2007; Lupien and Brown 2009).”
BackgroundAndrogen receptor co-regulatory networks in castration-resistant prostate cancer
Sung, Y. Y., & Cheung, E. C. W. (2013) · Endocrine Related Cancer · doi:10.1530/erc-13-0326 · Cited by 27
“Under this circumstance, a low level of FoxA1 expression may bring about a release of its transrepression activity on ‘gained’ ARBS, resulting in a transcriptional program that may contribute to cancer progression and thus associated with http://erc.endocrinology-journals.org q 2014 Society for Endocrinology DOI: 10.1…”
BackgroundInfluentialPerets, R., Kaplan, T., Stein, I., Hidas, G., Tayeb, S., Avraham, E., Ben‐Neriah, Y., Simon, I., & Pikarsky, E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046467 · Cited by 27
“data set that analyzed androgen bound promoters in the presence of androgen [16] we found a GC content of 52.”
BackgroundKalet, B. T., Anglin, S. R., Handschy, A. V., O’Donoghue, L. E., Halsey, C., Chubb, L. S., Korch, C. T., & Duval, D. L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068815 · Cited by 30
“Ets1 has also been shown to directly interact with several members of the nuclear hormone receptor family including the vitamin D receptor, ERa, androgen receptor and the peroxisome proliferator-activated receptor-a (PPARa) to induce ligand independent transcriptional activation [26,27].”
BackgroundETS Transcription Factor Expression and Conversion During Prostate and Breast Cancer Progression
Watson, D. K., Turner, D. P., Scheiber, M. N., Findlay, V. J., & Watson, P. M. (2010) · The Open Cancer Journal · doi:10.2174/1874079001003010024 · Cited by 30
“In addition to ETS-mediated transcriptional activation of multiple genes associated with cancer progression, additional mechanistic insights is provided by analysis of androgen receptor (AR) genomic targets demonstrated an enrichment of ETS transcription factor family and an interaction between the AR and ETS1 at a su…”
BackgroundAndrogen Receptor Modulators: A Marriage of Chemistry and Biology
McEwan, I. J. (2013) · Future Medicinal Chemistry · doi:10.4155/fmc.13.69 · Cited by 25
Mapping Protein–DNA Interactions Using ChIP-Sequencing
Massie, C. E., & Mills, I. G. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-376-9_11 · Cited by 29
Self-citationYang-tonifying traditional Chinese medicinal plants and their potential phytoandrogenic activity
Munyangaju, J. E., Miao, L., Fan, G., ORANG-OJONG, B. B., Hu, Z., Zhang, J., Gao, X., & Zhu, Y. (2014) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(14)60040-6 · Cited by 26
Zaman, N., Giannopoulos, P. N., Chowdhury, S. F., Bonneil, É., Thibault, P., Wang, E., Trifiro, M. A., & Paliouras, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113190 · Cited by 24
“High-throughput gene expression microarray approaches described in CaP cells have identified hundreds of androgenregulated genes and also characterized genome-wide AR recruitment sites [66,67,68,69].”
BackgroundEvaluation of ERG responsive proteome in prostate cancer
Tan, S., Furusato, B., Fang, X., He, F., Mohamed, A. A. M., Griner, N. B., Sood, K., Saxena, S., Katta, S., Young, D., et al. (2013) · The Prostate · doi:10.1002/pros.22731 · Cited by 24
“In the context of prostate epithelium, MAOA is regulated by androgens through promoter-upstream glucocorticoid/androgen response elements [51].”
BackgroundRegulation of the transcriptional activation of the androgen receptor by the UXT-binding protein VHL
Chen, S., Chen, K., Zhang, Q., Cheng, H., & Zhou, R. (2013) · Biochemical Journal · doi:10.1042/bj20121711 · Cited by 22
Non-canonical androgen signaling pathways and implications in prostate cancer
Dahiya, V., & Bagchi, G. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2022.119357 · Cited by 25
Rondeau, G., Abedinpour, P., Chrastina, A., Pelayo, J. T., Borgström, P., & Welsh, J. (2018) · Scientific Reports · doi:10.1038/s41598-018-20451-9 · Cited by 22
Chromatin binding by the androgen receptor in prostate cancer
Itkonen, H. M., & Mills, I. G. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.09.037 · Cited by 24
“This has lead to testable predictions of associations between the androgen receptor and a number of transcription factors including ETS1 (Massie et al., 2007), ERG (Yu et al.”
BackgroundSelf-citationRationale for the development of alternative forms of androgen deprivation therapy
Kumari, S., Senapati, D., & Heemers, H. V. (2017) · Endocrine Related Cancer · doi:10.1530/erc-17-0121 · Cited by 21
Chen, Y., & Sawyers, C. L. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.04.022 · Cited by 22
“This finding confirms the prediction of an earlier study that showed enrichment of ETS motifs adjacent to AR binding sites (Massie et al., 2007).”
ResultEnvironmental endocrine disruptors: does a sex-related susceptibility exist?
Bulzomi, P., & Marino, M. (2011) · Frontiers in bioscience · doi:10.2741/3867 · Cited by 21
“These non-canonical sites, some of which are frequently repeated, are important for enhancer promoter function (25, 26).”
BackgroundRosati, R., Patki, M., Chari, V., Selvakumar, D., McFall, T. B., Saxton, J., Kidder, B. L., Shaw, P. E., & Ratnam, M. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.745596 · Cited by 20
“ETS elements are commonly enriched at or in the vicinity of AR-binding sites in the chromatin (51, 52), and indeed physical association of AR has been suggested with ETV1 (53) and ETS1 (51).”
Zboralski, D., Böckmann, M., Zapatka, M., Hoppe, S., Schoeneck, A., Hahn, S. A., Schmiegel, W., & Schwarte‐Waldhoff, I. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-215 · Cited by 17
“Likewise, it has been shown earlier that the androgen receptor drives the expression of ETS transcription factors and can then be co-dependent on ETS factors for its recruitment to a subset of promoters [ 44 ].”
BackgroundCampagna, R., Brunelli, L., Airoldi, L., Fanelli, R., Håkansson, H., Heimeier, R. A., Boever, P. D., Boix, J., Llansola, M., Felipo, V., et al. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfr156 · Cited by 20
“These proteins are directly regulated by AR (Chuan et al., 2006; Massie et al., 2007; Nishimura et al., 2003).”
BackgroundTakayama, K., & Inoue, S. (2015) · Briefings in Functional Genomics · doi:10.1093/bfgp/elv057 · Cited by 19
Direct androgen regulation of PDE5 gene or the lack thereof
Lin, C.-S., Xin, Z., Namiki, M., Albersen, M., Müller, D., & Lue, T. F. (2013) · International Journal of Impotence Research · doi:10.1038/ijir.2013.11 · Cited by 18
Characterisation of the androgen regulation of glycine N-methyltransferase in prostate cancer cells
Ottaviani, S., Brooke, G. N., Brown, C. O., Waxman, J. H., Ali, S., & Buluwela, L. (2013) · Journal of Molecular Endocrinology · doi:10.1530/jme-13-0169 · Cited by 20
“With the aim of understanding the AR-regulated gene network in either androgen dependent or CRPC, global AR binding events have been mapped, initially using microarrays of gene promoter regions (Massie et al. 2007) and later by genometiled arrays (Wang et al.”
Barthold, J. S., Wang, Y., Robbins, A. K., Pike, J. W., McDowell, E. N., Johnson, K. J., & McCahan, S. M. (2013) · Biology of Reproduction · doi:10.1095/biolreprod.113.112953 · Cited by 18
“Notably, our PAINT analysis also showed enrichment of binding sites for ETS1 and ELK1, two transcription factors that also interact with AR to regulate expression of androgen-responsive genes in prostate cancer cells [43, 44] and could potentially function as coregulators in the gubernaculum.”
BackgroundChen, S., Wan, P., DING, W., Li, F., He, C., Chen, P., Li, H., Hu, Z., Tan, W., & Li, J. (2013) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2013.1359 · Cited by 17
“AR binds at a distinct androgen-response element (ARE) in the Cdc6 promoter that is functionally required for androgen-dependent Cdc6 transcription (6-9).”
Interrogating genomic and epigenomic data to understand prostate cancer
Kim, J., & Yu, J. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2011.12.003 · Cited by 20
“In 2007, coupling AR ChIP with ENCODE tiling arrays Takayama et al. identified 10 AR binding sites and validated AR recruitment to these genes[64], while using proximal promoter microarrays Massie et al. revealed AR binding to 1532 genomic sites and, for the first time, suggested novel pathways of androgen signaling c…”
BackgroundInfluentialSequencing the transcriptional network of androgen receptor in prostate cancer
Chng, K. R., & Cheung, E. C. W. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.11.009 · Cited by 17
“The genomic location of ARBS in prostate cancer cell line models has been interrogated by several groups using chromatin immunoprecipitation coupled to microarray (ChIP–chip) [16–18].”
MethodHeemers, H. V. (2014) · International Journal of Biological Sciences · doi:10.7150/ijbs.8479 · Cited by 17
“Physical and functional interaction between these TFs and AR occurred in an ARBS-selective and interdependent manner [79, 80, 83].”
BackgroundMethodGlobal Identification of Androgen Response Elements
Massie, C. E., & Mills, I. G. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-243-4_15 · Cited by 18
Self-citationFunctional implications and therapeutic targeting of androgen response elements in prostate cancer
Senapati, D., Sharma, V., Rath, S. K., Rai, U., & Panigrahi, N. (2023) · Biochimie · doi:10.1016/j.biochi.2023.07.012 · Cited by 19
Ryan, G. E., Bohaczuk, S. C., Cassin, J., Witham, E. A., Shojaei, S., Ho, E. V., Thackray, V. G., & Mellon, P. L. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111286 · Cited by 17
Callen, D. F. (2010) · Oncology Reports · doi:10.3892/or_00000731 · Cited by 15
Son, B., Eto, M., Oura, M., Ishida, Y., Taniguchi, S., Ito, K., Umeda‐Kameyama, Y., Kojima, T., & Akishita, M. (2019) · Gerontology · doi:10.1159/000499826 · Cited by 16
Chromatin Immunoprecipitation (ChIP) Methodology and Readouts
Massie, C. E., & Mills, I. G. (2009) · Methods in Molecular Biology · doi:10.1007/978-1-60327-575-0_7 · Cited by 13
Self-citationTargeting extra-gonadal androgens in castration-resistant prostate cancer
Grist, E., Bono, J. S. D., & Attard, G. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.09.006 · Cited by 15
“Furthermore, androgen regulated genes were also found to be expressed at high levels in CRPC compared with benign prostate epithelia [34].”
BackgroundHES5 silencing is an early and recurrent change in prostate tumourigenesis
Massie, C. E., Spiteri, I., Ross‐Adams, H., Luxton, H. J., Kay, J. D., Whitaker, H. C., Dunning, M., Lamb, A. D. G., Ramos‐Montoya, A., Brewer, D. S., et al. (2015) · Endocrine Related Cancer · doi:10.1530/erc-14-0454 · Cited by 14
Self-citationAndrogen Receptor-Mediated Growth Suppression of HPr-1AR and PC3-Lenti-AR Prostate Epithelial Cells
Kim, Y., Chen, C., & Bolton, E. C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0138286 · Cited by 12
“Although we have not interrogated AR occupancy at CDK4 and CDK6 in HPr-1AR and PC3-Lenti-AR, an AR-occupied region was identified 530 bp upstream of the transcription start site of CDK4 in LNCaP cells [92].”
BackgroundCanonical androgen response element motifs are tumor suppressive regulatory elements in the prostate
Chen, X., Augello, M. A., Liu, D., Lin, K., Hakansson, A., Sjöström, M., Khani, F., Deonarine, L. D., Liu, Y., Travascio-Green, J., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-53734-z · Cited by 17
ETS-1 in tumor immunology: implications for novel anti-cancer strategies
Wang, S., Wan, L., Zhang, X., Fang, H., Zhang, M., Li, F., & Yan, D. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1526368 · Cited by 15
Thevendran, R., Tang, T., & Citartan, M. (2023) · Biotechnology Journal · doi:10.1002/biot.202200092 · Cited by 13
Androgen enhances the activity of ETS-1 and promotes the proliferation of HCC cells
Ren, H., Ren, B., Zhang, J., Zhang, X., Li, L., Meng, L., Li, Z., Li, J., Gao, Y., & Ma, X. (2017) · Oncotarget · doi:10.18632/oncotarget.22669 · Cited by 11
“uncovered a potential interaction between ETS-1 and AR at a subset of AR promoter targets by using chromatin immunoprecipitation with on-chip detection of genomic fragments in prostate cancer cells [14].”
BackgroundPutting chromatin immunoprecipitation into context
Zecchini, V. R., & Mills, I. G. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22080 · Cited by 12
“By combining these observations with a functional association between the androgen receptor and ETS1 in a cell line Massie et al., concluded that these overexpressed ETS transcription factors may affect AR signalling in prostate tumours [Alipov et al., 2005; Massie et al., 2007].”
BackgroundInfluentialSelf-citationHuhtaniemi, R., Sipilä, P., Junnila, A., Oksala, R., Knuuttila, M., Mehmood, A., Aho, E., Laajala, T. D., Aittokallio, T. A., Laiho, A., et al. (2022) · iScience · doi:10.1016/j.isci.2022.104287 · Cited by 15
“In line with these data, previous studies have shown ADRB2 to be an AR-regulated gene (Braadland et al., 2015; Guthrie et al., 1990; Massie et al., 2007) and indicated that ADRB2 is associated with luminal differentiation (Braadland et al., 2019).”
ResultAndrogen Receptor Drives Transcription of Rat PACAP in Gonadotrope Cells
Grafer, C. M., & Halvorson, L. M. (2013) · Molecular Endocrinology · doi:10.1210/me.2012-1378 · Cited by 10
Identification of Transcription Factor–DNA Interactions In Vivo
Odom, D. T. (2011) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-90-481-9069-0_8 · Cited by 12
“This observation led eventually to similar pioneering discoveries in tissue-specific transcriptional regulation, including with Estrogen Receptor [40] and Androgen Receptor [41].”
BackgroundJariwala, U., Cogan, J. P., Li, J., Frenkel, B., & Coetzee, G. A. (2008) · The Prostate · doi:10.1002/pros.20893 · Cited by 12
“Coregulators, on the other hand, are DNA-binding proteins that recognize specific DNA sequences near the AR and modulate its activity either positively or negatively (10-15).”
BackgroundDiNatale, A., Worrede, A., Iqbal, W., Marchioli, M., Toth, A., Sjöström, M., Zhu, X., Corey, E., Feng, F. Y.-C., Zhou, W., et al. (2022) · Cancer Research Communications · doi:10.1158/2767-9764.crc-22-0262 · Cited by 12
“Conventional AREs are 15-bp palindromic sequence, but the AR can also bind to ARE half-sites with the sequence 5 -AGAACA-3 (34).”
Hsiao, J. J., Ng, B. H., Smits, M. M., Martinez, H. D., Jasavala, R. J., Hinkson, I. V., Fermin, D., Eng, J. K., Nesvizhskii, A. I., & Wright, M. E. (2015) · Molecular Endocrinology · doi:10.1210/me.2015-1021 · Cited by 9
Hernández-Díaz, I., Giráldez, T., Morales, S., Hernández, G., SALIDO, E. C., Canessa, C. M., & de la Rosa, D. Á. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00130.2012 · Cited by 9
“A fragment of rat hnRNP A2/B1 promoter encompassing 2,208 and 68 bp relative to the translation start site was amplified by PCR using rat genomic DNA as template (Table 1) and cloned using KpnI and SacI sites in pGL4.”
BackgroundInfluentialFunctional Role of WT1 in Prostate Cancer
Fraizer, G. C., Eisermann, K., Brett-Morris, A., Bazarov, A., Nock, S., Ghimirey, N., & Kuerbitz, S. J. (2016) · Codon Publications eBooks · doi:10.15586/codon.wt.2016.ch14 · Cited by 8
Anderson, N. K., Goodwin, S. E., Schuppe, E. R., Dawn, A., Preininger, D., Mangiamele, L. A., & Fuxjager, M. J. (2022) · Hormones and Behavior · doi:10.1016/j.yhbeh.2022.105248 · Cited by 8
Emons, J. A. M., Dutilh, B. E., Decker, E., Pirzer, H., Sticht, C., Gretz, N., Rappold, G., Cameron, E. R., Neil, J. C., Stein, G. S., et al. (2011) · Journal of Endocrinology · doi:10.1530/joe-10-0219 · Cited by 7
“We assumed that the probability of functional regulation is higher in genes that contain multiple conserved binding motifs, as found for some of the target genes of the ELK1 family member Ets1 and the androgen receptor (Massie et al. 2007).”
BackgroundEivers, S. B., & Kinsella, B. T. (2016) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2016.06.011 · Cited by 7
Terminal and progenitor lineage-survival oncogenes as cancer markers
Vias, M., Ramos‐Montoya, A., & Mills, I. G. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2008.09.002 · Cited by 7
Self-citationAndrogen aggravates aortic aneurysms via suppression of PD-1 in mice
Mu, X., Liu, S., Wang, Z., Jiang, K., McClintock, T., Stromberg, A. J., Tezanos, A. G. V., Lee, E. S., Curci, J. A., Gong, M. C., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci169085 · Cited by 6
“We analyzed a 5 kb mouse PD-1 promoter DNA sequence to identify androgen response elements (AREs) containing AGAACA or TGTTCT hex-amers, which are known to bind the AR effectively (32).”
MethodChauhan, G., & Heemers, H. V. (2021) · Cancers · doi:10.3390/cancers13163947 · Cited by 7
Expression Patterns and Corepressor Function of Retinoic Acid-induced 2 in Prostate Cancer
Besler, K., Węglarz, A., Keller, L., Amsberg, G. V., Bednarz‐Knoll, N., Offermann, A., Stoupiec, S., Eltze, E., Semjonow, A., Boettcher, L., et al. (2022) · Clinical Chemistry · doi:10.1093/clinchem/hvac073 · Cited by 6
Nuclear Receptors in Ovarian Function
Dinh, D. T., & Russell, D. L. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-11836-4_3 · Cited by 6
Ratnam, M., Patki, M., Gonit, M., & Trumbly, R. J. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6182-1_6 · Cited by 6
“ETS1 may also directly associate with AR but its physiological signi fi cance is yet to be understood [ 48 ] .”
BackgroundChallenges and Opportunities of Genomic Approaches in Therapeutics Development
Gray, J. S., & Campbell, M. J. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0849-4_7 · Cited by 5
The Effect of AR Overexpression on Androgen Signaling in Prostate Cancer
Urbanucci, A., Waltering, K. K., Mills, I. G., & Visakorpi, T. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6182-1_12 · Cited by 5
Self-citation
Metadata
- Authors
- Massie, C. E., Adryan, B., Barbosa‐Morais, N. L., Lynch, A. G., Tran, M. G., Neal, D. E., & Mills, I. G.
- Affiliations
- University of Cambridge (GB)
- MRC Laboratory of Molecular Biology (GB)
- Corresponding author
- Massie, Charles E
- Mills, Ian G
- ORCID
- Venue
- The EMBO Reports
- Published
- 2007-08-17
- Volume
- 8
- Issue
- 9
- Pages
- 871-878
- ISSN
- 1469-221X (ISSN-L)
- 1469-3178
- PMC
- PMC1950328
- OpenAlex
- W2030465046
- Cited by
- 259
- References
- 25
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 6 · 2023: 8 · 2022: 10 · 2021: 6 · 2020: 5 · 2019: 6 · 2018: 9 · 2017: 15 · 2016: 13 · 2015: 12 · 2014: 14 · 2013: 27 · 2012: 24
- FWCI
- 19.95
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- cc-by-nc-nd
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- EMBO Reports (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Research Portal (Queen's University Belfast) (submittedVersion)
- Funders
- National Institute for Health and Care Research (CL-2006-14-006)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- androgen receptor, ETS1, transcription factor binding sites, androgen response element, prostate cancer, transcriptional regulation, protein-protein interaction
- MeSH terms
- Base Sequence, Binding Sites, Humans, Molecular Sequence Data, Promoter Regions, Genetic, Protein Binding, Receptors, Androgen, Genome, Human, Sequence Analysis, DNA, Cell Line, Tumor, Chromatin Immunoprecipitation, Proto-Oncogene Protein c-ets-1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.